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Protein interactions form a network whose structure
drives cellular function and whose organization
informs biological inquiry. Using high-throughput
affinity-purification mass spectrometry, we identify
interacting partners for 2,594 human proteins in
HEK293T cells. The resulting network (BioPlex) con-
tains 23,744 interactions among 7,668 proteins with
86% previously undocumented. BioPlex accurately
depicts known complexes, attaining 80%–100%cov-
erage for most CORUM complexes. The network
readily subdivides into communities that correspond
to complexes or clusters of functionally related pro-
teins. More generally, network architecture reflects
cellular localization, biological process, and molecu-
lar function, enabling functional characterization of
thousandsof proteins.Network structure also reveals
associations among thousands of protein domains,
suggesting a basis for examining structurally related
proteins. Finally, BioPlex, in combination with other
approaches, can be used to reveal interactions of
biological or clinical significance. For example, muta-
tions in the membrane protein VAPB implicated in fa-
milial amyotrophic lateral sclerosis perturb a defined
community of interactors.INTRODUCTION
A central goal in cell biology is to describe the molecular pro-
cesses that drive cellular function. Although these are genomi-
cally encoded, they are executed by the proteome. The prote-
ome can be viewed as constellations of interacting protein
modules organized into signal transduction networks, molecu-
lar machines, and organelles. However, our knowledge of pro-
teome architecture is fragmentary, as is our conception of how
protein interconnectivity is influenced by genetic and cellular
variation.Our understanding of mammalian proteome structure has
emerged from five strategies. First, focused biochemical studies
have revealed stablemacromolecular complexes. Second, affin-
ity purification of epitope-tagged proteins followed by mass
spectrometry (AP-MS) has identified proteins associated with
baits from many protein families, including deubiquitinating en-
zymes (Sowa et al., 2009), histone deacetylases (Joshi et al.,
2013), and chaperones (Taipale et al., 2014). Third, complemen-
tary approaches involving either target-specific antibodies for
immunoprecipitation (IP)-MS or correlation profiling of soluble
protein assemblies have identified many complexes (Havugi-
mana et al., 2012; Malovannaya et al., 2011). Fourth, yeast
two-hybrid (Y2H) analysis of 14,000 human open reading
frames (ORFs) has identified binary protein interactions (Rolland
et al., 2014). Finally, several databases archive protein interac-
tions from literature (Franceschini et al., 2013; Licata et al.,
2012; Ruepp et al., 2010; Stark et al., 2011; Warde-Farley
et al., 2010). Although these repositories allow in silico inter-
action network construction, many literature interactions are
context dependent, and the stringency of criteria used to identify
interactions varies across studies. Thus, databases vary in con-
tent and quality.
Given this perspective, mapping globally the human protein in-
teractions within a single cell type in a physiological context and
understanding how network architecture depends upon genetic
and physiological variation remain daunting objectives. Inherent
challenges include (1) the myriad genes, isoforms, and modifica-
tion states encoded by the human genome; (2) the low abun-
dance of many proteins, which limits detection; (3) themany tran-
sient interactions that complicate signaling network mapping;
and (4) the prevalence of membrane proteins, which often re-
quires specialized methods for purification. Although no single
approach can address all challenges, several attributes of AP-
MS will facilitate delivery of a ‘‘first-pass’’ global human interac-
tome. One advantage is its exquisite sensitivity. In addition, unlike
binary methods, AP-MS determines components within multi-
protein complexes. AP-MS has previously mapped a substantial
fraction of yeast (Gavin et al., 2002; Ho et al., 2002; Krogan et al.,
2006) and Drosophila (Guruharsha et al., 2011) interactions.
Here, we report AP-MS analysis of 2,594 baits to produce a
human interaction map spanning 23,744 interactions amongCell 162, 425–440, July 16, 2015 ª2015 Elsevier Inc. 425
7,668 proteins. This network represents the first phase of a long-
term effort to profile the entire human ORFEOME collection via
AP-MS and generate a comprehensive map of human protein
interactions. At the time of publication, the latest version of the
publicly available BioPlex network includes 5,884 AP-MS exper-
iments with over 50,000 interactions. Although we detected
many known interactions, validating the methodology, most
have not been reported, reflecting targeting of many under-stud-
ied proteins and highlighting AP-MS sensitivity. In addition, we
identified 354 communities representing known and previously
unidentified complexes. Moreover, integration of protein domain
and localization information revealed enrichment of domains
within subnetworks and highly correlated localization within
complexes, while suggesting biological roles for proteins of
unknown function. Finally, we merge isobaric labeling with
AP-MS to quantify how genetic variation alters interactions of
VAPB variants associated with familial amyotrophic lateral
sclerosis (ALS), revealing mutation-specific loss and gain of in-
teractions. Ultimately, BioPlex unveils both individual protein
functions and global proteome organization.
RESULTS
Achieving Rapid and Reliable AP-MS
Globally applying AP-MS requires both high capacity and
rigorous quality control. As depicted in Figure 1A and described
in the Supplemental Experimental Procedures, we have initiated
high-throughput lentiviral expression and AP-MS profiling of
C-terminally FLAG-HA-tagged baits from 13,000 protein-coding
ORFs within the sequence-validated Human ORFEOME collec-
tion v. 8.1 (Yang et al., 2011). Using this system, single biolog-
ical replicates of up to 600 baits have been expressed in
HEK293T cells, immuno-purified, and analyzed via mass spec-
trometry in technical duplicate each month. Baits have been
processed in batches corresponding to 96-well plates within
the ORFEOME, selected randomly from the library. Peptides
and proteins were identified and filtered within each IP to a
1% false discovery rate (FDR), with additional filters to control
network FDR (Supplemental Experimental Procedures). Given
the scale of this endeavor, a paramount concern is data integ-
rity. In addition to clone validation and quality control during
the wet-lab pipeline, automated evaluation of MS perfor-
mance, comparison of LC-MS technical duplicates, automated
validation of bait protein detection, and inclusion of positive
(RAB11B) and negative (GFP) controls ensured consistent
data quality (Figure S1A and Supplemental Experimental Proce-
dures). Although analysis of all protein-coding genes in the
Human ORFEOME is ongoing, we focus here on the first
2,594 AP-MS experiments (Table S1).
Global Protein Interaction Mapping via CompPASS-Plus
Our work employs CompPASS, which has identified high-confi-
dence interacting proteins (HCIPs) for up to 100 baits (Sowa
et al., 2009). CompPASS quantifies enrichment of each protein
in each IP, relative to other unrelated AP-MS datasets, based
on abundance, detection frequency, and reproducibility. HCIPs
are identified using the normalized weighted D score (NWD
score) and Z score (Figure S2A).426 Cell 162, 425–440, July 16, 2015 ª2015 Elsevier Inc.To improve performance across thousands of AP-MS data-
sets, we developed CompPASS-Plus, a Naive Bayes classifier
that recognizes HCIPs using several features (Figure S2A). In
addition to CompPASS scores, features measure batch varia-
tions, overall spectral counts, unique peptide counts, and pro-
tein detection frequency. Shannon entropy quantifies a protein’s
consistency of detection across technical duplicate LC-MS ana-
lyses, which removes inconsistent protein identifications and
minimizes LC carry-over artifacts (Figure S2B). Because Comp-
PASS-Plus must distinguish HCIPs from background proteins
and incorrect protein identifications, proteins are sorted into
three classes (Figure S2C). Since the few (0.05%) incorrect pro-
tein identifications that survive filtering earn NWD and Z scores
that most closely resemble those of HCIPs, sorting incorrect
protein identifications separately improves accuracy. To train
CompPASS-Plus, incorrect protein identifications weremodeled
using decoy proteins that survived peptide- and protein-level
FDR filtering, while HCIPs were modeled using bait-prey pairs
reported in STRING (Franceschini et al., 2013) or GeneMania
(Warde-Farley et al., 2010); all other bait-prey pairs modeled
non-specific background. To minimize over-fitting, each AP-
MS experiment was scored using a classifier trained excluding
data from its own IP and other IPs on the sameplate (Figure S2D).
CompPASS-Plus assigns each bait-prey pair in every AP-MS
experiment three scores, reflecting the probability that it corre-
sponds to a wrong identification, a background protein, or an
HCIP. Bait-prey pairs that receive an interaction score of at least
0.75 are considered HCIPs.
CompPASS-Plus effectively distinguishes interactions from
background. When AP-MS data were aligned with high-confi-
dence interactions from CORUM (Ruepp et al., 2010), high-
scoring bait-prey pairs were most frequently confirmed (Fig-
ure S2E). Similarly, over 87% of decoy proteins were classified
as incorrect identifications (Figure S2F). When used to classify
known true- and false-positive interactions across 30 biological
replicate positive and negative control AP-MS experiments,
CompPASS-Plus identified known interactions with high sensi-
tivity and specificity (Figure S2G).
The utility ofCompPASS-Plus to identify HCIPs from individual
AP-MS experiments is depicted in Figures 1B and 1C. From
495 proteins detected with CDK1, only 16 remained after
filtering, and all but 2 (ICK and PKMYT1) are known CDK1-asso-
ciated proteins or substrates. Notably, all HCIPs for XRCC2 and
EIF4E are known (Figure 1C)—XRCC2 recovers the entire
BCDX2 complex (Masson et al., 2001), while EIF4E binds the
EIF4F complex, EIF4E-binding proteins 1 and 2, and its known
interactor ANGEL1 (Gosselin et al., 2013). Similarly, 11 of 13
HCIPs for filamentous SEPT1 GTPase are either related SEPT
proteins or known SEPT1 interactors. Other examples are high-
lighted in Figures S1B and S1C, comparing BioPlex with interac-
tions reported by Y2H (Rolland et al., 2014) or in a previous
AP-MS study of DUBs (Sowa et al., 2009).
An AP-MS Map of the Human Interactome
Although each AP-MS experiment identifies proteins associated
with one bait, when all are combined, the interactions form a
model of the interactome. This network, whose largest com-
ponent is depicted in Figure 2A, includes 23,744 interactions
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Figure 1. High-Throughput Interaction Mapping via AP-MS
(A) AP-MS platform: (1) a lentiviral library of 13,000 FLAG-HA-tagged ORFs was constructed from the Human ORFEOME; (2) 293T cells were infected and
expanded under puromycin selection; (3) baits and preys were immuno-purified; (4) tryptic digests were analyzed in technical duplicate by LC-MS; (5) proteins
were identified and specific interactors found; (6) and interactions were assembled to model the human interactome. Up to 600 AP-MS experiments may be
completed per month.
(B) CompPASS-Plus extracts 16 interactors for bait CDK1 from a background of nearly 500 proteins.
(C) Interaction maps for baits XRCC2, EIF4E, and SEPT1 (red). Nearly all interactions have been previously described. Interactors were identified from back-
grounds of 487, 778, and 749 proteins, respectively.
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Figure 2. BioPlex Network Properties
(A) BioPlex. The largest component is depicted.
(B) Vertex degree distribution of all proteins in
BioPlex. The dashed line represents the best-
fit power law (see Supplemental Experimental
Procedures).
(C) Histogram depicting the number of degrees
separating all protein pairs.
(D) Functional classifications of baits and preys
assigned by PANTHER and compared against the
functional distributions of our HEK293T proteome
and the entire human UniProt proteome.connecting 7,668 gene products (Table S2). We call this network
BioPlex (biophysical interactions of ORFEOME-derived com-
plexes) and provide a graphical viewer (Figure S3). Of 2,594
baits, 319 were not found to interact with any other proteins in
293T cells under basal conditions as C-terminally tagged pro-
teins (Table S1). The median bait interacted with six other pro-
teins, whereas the median gene product (including preys, as
well as baits) participated in three interactions, suggesting that
Bioplex underestimates interactions of proteins not yet targeted
for AP-MS.
Although the median interaction count for each protein is low,
significant variability is observed and the degree distribution is
skewed by proteins with many interacting partners, reflecting
coverage of proteins participating in large assemblies. When
plotted in log-log space (Figure 2B), the fraction of proteins
observed across the range of vertex degrees follows a linear
trend for degrees above 4 that is consistent with power law
behavior typical of scale-free networks (Barabasi and Albert,
1999) and has been observed in protein interaction and meta-
bolic networks (Vidal et al., 2011). In addition, fewer proteins
than expected participate in very few (i.e. less than five) interac-
tions, as indicated by the deviation from power law behavior for428 Cell 162, 425–440, July 16, 2015 ª2015 Elsevier Inc.low interaction counts. More than 98% of
protein pairs connect to each other, most
within five or fewer degrees of separation
(Figure 2C).
To accurately model the interactome,
BioPlex should sample proteins evenly
across functional categories. Functional
classification using PANTHER (Mi et al.,
2013) in conjunction with all UniProt pro-
teins (Magrane and Consortium, 2011)
revealed a distribution of baits and preys
that closely matched UniProt functional
categories (Figure 2D). Another consid-
eration is the influence of the AP-MS sys-
tem on the interaction network. Because
baits have been expressed in HEK293T
cells, we profiled the 293T proteome,
identifying 10,326 proteins and assigning
each to abundance percentiles (Fig-
ure S4A). HEK293T proteome functional
classification mimicked UniProt and
most closely resembled the distributionobserved for preys (Figure 2D). We then mapped the 293T pro-
teome onto BioPlex. As expected, 90% of preys were also
detected in 293T cells via total proteome analysis (Figure S4B);
the remaining 10% were only detected via AP-MS, suggesting
that their abundance was below detection limits without en-
richment. In contrast, only 60% of baits were detected in our
293T proteome (Figure S4B). This is not surprising because
bait selection was unbiased, and 293T cells only express a
fraction of ORFEOME-encoded proteins. Baits were drawn
evenly from across native 293T expression levels. In contrast,
preys were enriched in the upper third of the abundance range,
with proteins in the bottom 25% under-represented (Fig-
ure S4C). Though bait levels vary across 2,594 IPs, most were
detected at moderate levels (Figure S4D). Furthermore, bait
abundances and interaction counts were uncorrelated (Fig-
ure S4E). Although the extent of bait overexpression is difficult
to judge and varies across IPs, previous experimentation has
shown that overexpression has little effect on identification of
true interacting partners after CompPASS analysis (Sowa
et al., 2009). Overall, notwithstanding idiosyncrasies of the
293T expression system, the resulting network constitutes a
representative cross-section of the proteome.
BioPlex Recapitulates Known Complexes and Reveals
Thousands of New Interactions
Toassess its accuracy and completeness,we superimposedBio-
Plex onto high-confidence CORUM complexes detected via low-
throughput methods, attaining high overlap. When at least two
constituent proteins were selected as baits, more than 25% of
CORUM complexes were perfectly recapitulated by AP-MS (Fig-
ure 3A). Similarly, over 1/3 of complexes achieved at least 90%
coverage, whereas 1/2 were 80% complete and nearly 3/4 at-
tained at least 50%coverage. Proteinswithin a complex are often
highly interconnected, as for the Arp 2/3 and NuA4/Tip60-HAT
complexes and the Exosome. In contrast, RBBP7 belongs to a
large complex assembled from two smaller complexes, each of
which has been separately isolated by AP-MS: HDAC1/2-ING1-
SIN3A-SAP30-SAP18-RBBP4 (complex I) and ARID1A-ARID4B-
SMARCD1-SMARCC1-SMARC2-SMARCB1-SMARCA4 (com-
plex II) (Kuzmichev et al., 2002). Our RBBP7 analysis identified all
components of complex I except SAP18, possibly reflecting its
small size (153 amino acids), as well as a single component of
complex II (ARID4B). In contrast, SMARCD1 associated with
six of eight subunits of the complex II SMARC/ARID subcomplex
(Figure 3A). Thismay reflect relatively weaker interactions among
the subassemblies. Likewise, the CDK-activating kinase (CAK)
complex CDK7-CCNH-MNAT1 is a multifunctional protein ki-
nase that is involved in both CDK activation and in transcrip-
tion-coupled repair through the TFIIH complex. Although the
core kinase complex and its interactions with three TFIIH com-
plex components (ERCC2, ERCC3, and GTF2H1) were detected
using CDK7, CCNH, and MNAT1 as baits, several TFIIH compo-
nents were not detected (Figure 3A). This incomplete TFIIH com-
plex identification with tagged CAK could reflect stringent
washing or the relative abundance of CAK complexes versus
TFIIH complexes. To understand why many TFIIH complex
members were absent, we examined AP-MS data targeting
GTF2H3 that were acquired via our pipeline while this manu-
script was in preparation. Encouragingly, we detected interac-
tions with GTF2H1, GTF2H2, GTF2H4, and ERCC3, attaining
nearly complete coverage of this complex (data not shown).
Overlap with CORUM will continue to improve as the network
grows to include analysis of most human proteins.
To enable more extensive comparison, we compiled all
human physical interactions reported in CORUM, BioGRID
(Stark et al., 2011), GeneMania, STRING, and MINT (Licata
et al., 2012). The latter four databases accept a variety of
evidence in support of protein interactions, including high-
throughput techniques, and thus contain many more interac-
tions at correspondingly higher false-positive rates. Only phys-
ical interactions supported by direct experimental evidence
were included; interactions due to co-expression, co-localiza-
tion, text-mining, or predictions were excluded. Inter-database
overlap was limited, with fewer than 25% of interactions re-
ported by multiple databases (Figure 3B). Notwithstanding
such narrow agreement, interactions seen in BioPlex were
more frequently found in multiple databases (Figure 3B). This
suggests that BioPlex preferentially overlaps with the most
frequently reported interactions. Although interactions found
in all five databases were confirmed by AP-MS nearly 50% of
the time and more than 35% of interactions reported by fourdatabases were confirmed, only 2% of interactions unique to
just one database were observed (Figure 3C).
Approximately 84% of the 23,744 BioPlex interactions have
not been reported (Figure 3D), reflecting sampling of many
‘‘pioneer’’ proteins and increased analytical depth afforded by
new instrumentation. For further validation, we compared re-
ported subcellular localizations of interacting protein pairs as
an indirect measure of plausibility. Although co-localization
cannot guarantee physical association, interacting protein pairs
must at least partially co-localize. In contrast, false-positive
interacting proteins would localize randomly with respect to
each other. To assess co-localization, we mapped UniProt
subcellular localizations onto BioPlex. The tendency for co-
localized proteins to interact is measured by graph assortativity
(Supplemental Experimental Procedures). Positive assortativ-
ities indicate preferential interactions among proteins in the
same compartment, whereas values near zero imply random
interactions.
As an indirect validation, we calculated assortativities for
several databases and interaction datasets and compared
each with BioPlex (Figure 3E). Because localizations of proteins
in each dataset varied considerably, pairwise comparisons with
BioPlex were performed focusing on interactions that connected
proteins in both networks. Assortativities quantify each net-
work’s tendency to connect these shared proteins according
to subcellular localization. Pairwise analyses were also repeated
with randomized subcellular localizations. Although assortativ-
ities in each pairwise comparison varied due to differences in
the extent of biological characterization and quality of subcellular
localization information available for shared proteins, all net-
works exhibited non-random interactions. Proteins included in
both CORUMand BioPlex were well-characterized and predom-
inantly nuclear or cytoplasmic, attaining the highest coefficients.
In contrast, comparisons that included higher proportions of less
studied proteins exhibited reduced, though highly significant,
preferences for connecting proteins with shared localization.
Overall, BioPlex compared favorably with published interaction
networks: in five of seven cases, BioPlex showed a greater ten-
dency to connect co-localized proteins; in the remaining two
cases, differences were small and reflected in part interactions
missing from BioPlex because neither protein has been targeted
for AP-MS. This analysis suggests that the BioPlex network is at
minimum comparable in quality to previously published interac-
tion data, a conclusion that extends to the many unreported in-
teractions it contains.
BioPlex Community Structure Reveals the Interactome
Functional Organization
Although several BioPlex complexes have been highlighted by
comparison with CORUM, complexes may also be revealed
from network topology alone as clusters of highly interconnected
proteins. Because no prior knowledge is required, community
detection algorithms may associate new proteins with known
complexes and identify unknown complexes. We have em-
ployed a two-stage strategy to map BioPlex community struc-
ture, using clique percolation (Palla et al., 2005) to identify
256 communities that were further subdivided via modularity-
based clustering (Newman, 2004) into 354 communities andCell 162, 425–440, July 16, 2015 ª2015 Elsevier Inc. 429
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Figure 3. Evaluation of AP-MS Protein Interactions
(A) AP-MS interactions superimposed onto CORUM complexes. The pie chart depicts the fraction of complexes achieving the indicated coverage in BioPlex.
Only complexes containing two or more baits were considered. Five representative CORUM complexes: baits are colored blue, whereas preys are red and
proteins not observed by AP-MS are gray. Interactions among CORUM complex members are gray, whereas interactions confirmed by AP-MS are red.
(B) Physical protein interactions reported in BioGrid, CORUM, GeneMania, STRING, and MINT were merged. Left: overlap among databases. Right: overlap
among databases for interactions confirmed by AP-MS.
(C) Fraction of database interactions confirmed by AP-MS as a function of the number of supporting database reports. The composite interaction database was
filtered to include only interactions connecting one of 2,594 baits with proteins observed as baits or preys in the interaction network.
(legend continued on next page)
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subcommunities (Table S3). Community size varied from 2 to 140
proteins, though most included fewer than 20 members (Fig-
ure 4A). Most communities encompassed related proteins, as
84% were enriched for at least one GO term or Pfam domain
(Figure S5A). Moreover, many communities match known com-
plexes, forming a network that depicts interactome organization
(Figure 4B). Subsets of this network have been enlarged (Fig-
ure 4C) to reveal underlying protein interactions.
The power of community detection to retrieve known com-
plexes is exemplified by Figure 4C (i). Although the proteasome
emerged as one large community following clique percolation,
further modularity-based clustering subdivided the proteasome
into two clusters corresponding largely to its catalytic particle
(primarily PSMA and PSMB subunits) and regulatory particle
(primarily PSMC, PSMD, and UCHL5 subunits), as well as a
CUL5-TCEB1-RAB40 ubiquitin ligase complex that links with
the proteasome via the alternative cap protein PSME3 and
FAM192A. Chaperones that assist proteasome assembly (e.g.,
PSMG1/2, POMP) and other regulators (PAAF1 and FOXO7)
also cluster with the proteasome, along with proteins (e.g.,
ZFAND2B, CCDC74B, and C16orf70) that have no known pro-
teasomal connections.
A unique feature of clique percolation is that it allows proteins
to be shared among multiple communities. Such proteins often
physically connect or coordinate distinct cellular activities. Alter-
natively, specificity factors for enzymes involved in diverse reg-
ulatory processes may be shared with multiple communities.
For example, the community in Figure 4C (iii) contains a cluster
of protein phosphatase catalytic and regulatory subunits that
connects to a highly interconnected RNA polymerase cluster,
as well as a cluster of kinetochore components. Phosphorylation
controls both RNA polymerase and kinetochore function and
linkage to phosphatase components may reveal common regu-
latory factors and mechanisms for distinct target complexes.
Further examples include CDK (Figure 4C, vi), vesicle function
(Figure 4C, ii), LIM domain and homeobox transcription factor
(Figure 4C, v), and cullin ring ubiquitin ligase/signalosome (Fig-
ure 4C, iv) communities.
Many communities are united by shared traits that cause
member proteins to preferentially associate (Table S3; Fig-
ure S5A). Some match known complexes, such as the Mediator
(clusters 11a and 11b) and 43S translation pre-initiation com-
plexes (clusters 25a and 25b). Indeed, 33 known Mediator sub-
units separated into two subcomplexes and were devoid of
non-Mediator Complex connections (Figure S5B). Similarly,
cluster 73 contains the FTS1-HOOK1,2,3 protein complex
accompanied by TNFSF13B, whose association was until now
unknown. Such associations can reveal much about unknown
proteins: the little-known protein C11orf74 associates with 5
members of the intraciliary transport particle A (cluster 74). Not
only do its neighbors share biological functions and domains,
but all have been implicated in related ciliary disorders (cranioec-(D) 86% of AP-MS interactions have not been reported in the databases listed a
(E) Pairwise comparisons of BioPlex with published interaction networks were per
shared localization among proteins detected in both networks. Literature datas
interactions recently reported via yeast-two-hybrid (Rolland et al., 2014) and LC-
with randomized localizations as a control.todermal dysplasia 1–4, short-rib thoracic dysplasia 9). Finally,
community structure can reflect functional subtleties. Although
clusters 6a, 6b, and 6c uniformly regulate histone acetylation,
each comprises a different acetyltransferase complex and tar-
gets a distinct histone subset.
Protein Interactions Reveal Associations among
Functional Domains
Many proteins may be decomposed into domains or self-con-
tained modules that have independently evolved to perform
specific functions. Domains often recur in the proteome, per-
forming related functions within many proteins. Although
thousands of domains have been identified, the functions of
many are unknown. Because many domains mediate interac-
tions by binding complementary structures within other pro-
teins, analyzing interactions of their parent proteins may
provide functional insights. Such efforts would complement
previous attempts to characterize known or predicted domain
interactions (Boxem et al., 2008). We have mapped Pfam (Finn
et al., 2014) domains to each protein in BioPlex and identified
domain pairs whose parent proteins interact with unusual fre-
quency (Figure 5A). Although co-occurring domains do not
necessarily interact directly and may instead relate indirectly
through other protein features or shared function, these asso-
ciations nevertheless can provide insights into each domain’s
unique biology.
Across BioPlex, 2,968 domain pairs associated at a 1% FDR
(Table S4 and Figures S6A and S6B). Although many associa-
tions describe known relationships among familiar domains,
most link domains with no known connections. As expected,
proteins with protein kinase domains frequently interact with
proteins bearing cyclin N/C domains, reflecting cyclin-depen-
dent kinases. In addition, synaptobrevin associates with SNARE,
and septin-containing proteins co-occur. Similarly, TRiC chaper-
ones containing Cpn60 TCP1 domains associate with proteins
containing WD40 domains whose folding they facilitate (Fig-
ure S6C) (Spiess et al., 2004). Finally, as expected, SCAN-
domain-containing proteins self-associate (Figure S6D) and
frequently assort with KRAB and zf-C2H2 domains.
Amongunreporteddomain associations area subset that relate
domains of unknown functionwith other Pfamdomains, including
14-3-3, UBX, SCAN, and WD40 domains (Figure 5B). Proteins
bearing domains of unknown function provide context for re-
ported domain associations (Figures 5C–5H). For example, the
DUF2045 domain-containing protein KIAA0930 is surrounded
by 14-3-3 proteins (Figure 5C), raising the possibility that
KIAA0930 and the DUF2045 domain may participate in intra-
cellular signaling. Similarly, DUF1162 proteins VPS13A and
VPS13C interact with proteins containing UBX domains (Fig-
ure 5D). Each domain of unknown function presented in Figures
5C–5H is unaccompanied within its parent proteins, ruling out in-
fluence of other domains.bove.
formed, using graph assortativity to quantify preferential interaction in cases of
ets included BioGRID, CORUM, GeneMania, STRING, and MINT, as well as
MS correlation profiling (Havugimana et al., 2012). Each analysis was repeated
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BioPlex Aids Protein Subcellular Localization Prediction
Because proteins must exist in close proximity to physically
interact, the interactome necessarily reflects the subcellular
localizations of its proteins. Thus, we mapped subcellular local-
ization data fromUniProt onto BioPlex and calculated the enrich-
ment of each subcellular compartment among each protein’s
first and second degree neighbors (Table S5). While enrichment
could indicate that a protein associates with a compartment in
multiple ways, the simplest interpretation is that a protein at least
partially localizes to that compartment. Figure S7 displays pre-
dicted localizations for several proteins and complexes. Fig-
ure S7A depicts predicted localizations for proteasome subunits
and the subnetwork surrounding PSMA1 to illustrate its most
likely localizations. As expected, essentially all proteasome sub-
units are found in both nucleus and cytoplasm; the only ex-
ception is PSME3, the alternative regulatory cap protein that
clustered separately from the rest of the proteasome (Figure 4C,
i). Indeed, previous experiments have demonstrated that unlike
other proteasome subunits, PSME3 localizes specifically in the
nucleus (Wo´jcik et al., 1998). Other panels depict localizations
for CDKs and related proteins (Figure S7B), complex I of the
mitochondrial electron transport chain (Figure S7C), and the nu-
clear Mediator complex (Figure S7D), which are all consistent
with their known localization.
BioPlex Enables Characterization of Unknown Proteins
A motivation for unbiased mapping of the human interactome
is to explore the biology of uncharacterized proteins. BioPlex
contains interactions for 271 unstudied ORFs (Figure 6A) that
suggest functions and localizations of these proteins. As
described, 117 ORFs were assigned to at least one subcellular
location at a 1% FDR (Table S5 and Figure 6B). Of eight ORFs
predicted by AP-MS to localize to mitochondria, six are known
or suspected mitochondrial proteins (UniProt and/or http://
www.broadinstitute.org/pubs/MitoCarta/), and two (C1orf220
and C17orf39) have not been assigned any localization. For
these two proteins, among many others, their positions within
the AP-MS interaction network provide insights into their primary
subcellular localizations.
To highlight the information encoded by an uncharacterized
protein’s position in the AP-MS network, we provide several ex-
amples in Figure 6C. Inferences about each ORF’s specific inter-
actions, biological function, and localization are summarized
(Table S6). Three of these proteins have been characterized, af-
fording an opportunity to evaluate network predictions. In each
case, agreement was excellent. C15orf29 was found to interact
with proteins KATNA1 and KATNB1, which associate with the
cytoskeleton and participate in microtubule severing. Recently,Figure 4. Community Analysis of the AP-MS Interactome
(A) BioPlex communities: 256 initial communities were identified via 3-clique p
communities.
(B) Network of communities. Gray circles represent 354 BioPlex communities; cir
communities that share a common protein or were initially classified as a single co
highlight communities expanded in (C).
(C) Each box depicts communities highlighted in (B) at resolution sufficient to obs
communities that initially clustered together and subsequently split are rendered
multiple communities are gray, whereas interactions among members of a commC15orf29 was renamed KATNBL1 and may govern KATNA1 ac-
tivity. Similarly, C16orf57 has been renamedUSB1 and identified
as a nuclear protein that participates in RNA splicing and mRNA
processing (Mroczek et al., 2012). Furthermore, C7orf30 is
thought to act as a silencing factor for the mitochondrial ribo-
some (Fung et al., 2013). In contrast, little is known about
C15orf17, C4orf19, and C7orf46. As these proteins show, Bio-
Plex is a roadmap for exploring the uncharted expanses of the
proteome and illuminating the dark corners of cell biology.
Functional Validation of the VAPA/VAPB Interaction
Subnetwork
Perhaps the greatest value of BioPlex is the potential of its
interactions to inspire hypothesis-driven research into under-
explored areas of biological inquiry. To demonstrate this applica-
tion while further validating BioPlex, we examined a subnetwork
involving VAPB, previously found mutated in familial ALS, and
the related protein VAPA.
VAPA and B are ER-localized transmembrane proteins that
anchor proteins implicated in lipid dynamics, primarily lipid
transfer proteins (Lev et al., 2008). Lipid-transfer proteins, such
as oxysterol-binding proteins (OSBPs) and other VAPA/B-asso-
ciated proteins, contain FFAT motifs that interact with the
cytoplasmic MSP domain of VAPA/B (Kaiser et al., 2005).
VAPB and several interacting partners were found in BioPlex,
and VAPA was analyzed using the high-throughput pipeline dur-
ing manuscript preparation, yielding a highly interconnected
network (Figure 7A). As expected, VAPA and VAPB associated
with several OSBPs (Mesmin et al., 2013a), and other proteins
linked with membrane traffic or signaling, several of which
were seen reciprocally.
To validate the interactions found in 293T cells and to under-
stand how patient mutations in VAPB affect individual associa-
tions, we stably expressed VAPB and its mutants (VAPBT46I
and VAPBP56S) in SH-SY5Y cells and performed quantitative
AP-MS using tandem mass tagging (TMT) (see Supplemental
Experimental Procedures and Figure 7B). Biological triplicate
AP-MS complexes from all three variants were subjected to 9-
plex TMT with reporter ion quantification by LC-MS3-based
mass spectrometry. Many interactors identified in 293T cells
also associated with wild-type VAPB in SH-SY5Y cells (Fig-
ure 7C). Normalized reporter ion intensities revealed proteins
that displayed altered VAPB association with specific mutants
(Figure 7C), including increased association of the VAPBP56S
mutant with FAM82A2 (also called PTPIP51) as recently reported
(Stoica et al., 2014). Moreover, whereas previous studies indi-
cated that FAF1 associated equivalently with VAPBWT and
VAPBP56S in vitro (Baron et al., 2014), our in vivo results indicateercolation and subdivided via modularity-based clustering, resulting in 354
cle size is proportional to the number of member proteins. Gray edges connect
mmunity and were subdivided via modularity-based clustering. Labeled boxes
erve individual interactions. Proteins are grouped by community membership;
in similar hues; proteins shared among clusters are red. Interactions that span
unity share the color of that cluster.
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Figure 5. Detection of Associations, Including Domains of Unknown Function
(A) After mapping Pfam domains onto BioPlex, the numbers of proteins containing each domain were tallied. Numbers of interactions that linked one domain with
another were also determined. Contingency tables were then populated relating observation of one domain with the other, and Fisher’s exact test determined the
(legend continued on next page)
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that FAF1 associates more weakly with VAPBT46I and VAPBP56S
relative to VAPBWT, which is consistent with interaction via the
FFAT motif (Figure 7C).
To further validate enhanced association of LSG1 with
VAPBP56S (Figure 7C), we examined localization of EGFP-LSG1
and OSBP-EGFP with or without expression of VAPBWT or
VAPBP56S in HeLa cells. Importantly, VAPBP56S is known to
intrinsically aggregate. In cells not expressing exogenous VAP
proteins, EGFP-LSG1 displayed reticular ER localization, and
therefore binding to VAP, when expressed at low level and a
predominant cytosolic diffuse distribution at high expression
as seen previously with OSBP (Mesmin et al., 2013b) (Figure 7D).
This cytosolic distribution likely reflects VAP binding site
saturation in the ER membrane. Accordingly, VAPBWT overex-
pression strongly increased the association of EGFP-LSG1
and OSBP with the ER (Figures 7E and 7G). In contrast, expres-
sion of aggregation-prone VAPBP56S led to recruitment of
EGFP-LSG1, but not of OSBP, into the aggregates (Figures 7F
and 7H). Additionally, a pool of LSG1, but not of OSBP, co-
localized with the small VAPBP56S pool that remained diffusely
distributed throughout the ER (Figures 7G and 7H). These
observations confirm that the P56S mutation within the
MSP domain of VAPB reduced FFAT motif-dependent interac-
tions, while enhancing interactions with LSG1, which does not
contain an FFAT motif. These data demonstrate the potential
for BioPlex to inform and enhance focused study of individual
proteins.
DISCUSSION
High-Throughput AP-MS Complements Other Global
Interaction Mapping Approaches
To date, most near-global studies of human protein interactions
have relied upon Y2H, which is amenable to automation and
measures binary, and often direct, interactions. However, as
emphasized through BioPlex community analysis, many interac-
tions involve large protein assemblies whose detection is facili-
tated by AP-MS andmay not be detectable as binary complexes
due to complex structural interactions. An example is the Medi-
ator complex. AP-MS using 5 subunits (MED7, MED19, CDK8,
CDK19, and CCNC) identified nearly all Mediator subunits, with
each bait capturing 23–37 subunits (Figure S5B and Table S2).
In contrast, analysis of baits CCNC, MED4, MED18, MED20,
MED25, MED28, and MED30 with a Y2H library containing 16
Mediator subunits yielded 24 partners, only one of which was a
known Mediator subunit (Rolland et al., 2014). This reflects that
Mediator architecture involves co-assembly of multiple subunits
rather thanmodular assembly most easily captured via Y2H. The
ability of AP-MS to pinpoint primary and secondary interactions,
while simultaneously recognizing independent complexes withlikelihood of a non-random association between the two domains. This proces
hypothesis testing (Benjamini and Hochberg, 1995).
(B) Heatmap depicting significant domain associations involving domains of unkno
a 1% FDR. Labels indicate domain associations highlighted in (C)–(H).
(C–H) Interaction networks corresponding to associated domain pairs. Blue vert
whereas red vertices indicate proteins containing the associated domain; gray nod
multiple testing correction. Schematics depicting the domain structure of each cshared components, is the cornerstone of our large-scale
network construction.
Network structures for multi-functional and dynamic protein
associations will emerge as a larger fraction of the proteome
is sampled as baits. Surprisingly, 86% of BioPlex interactions
have not been reported. This reflects (1) interrogation of many
poorly studied proteins; (2) AP-MS sensitivity, enabling detec-
tion of low abundance proteins; (3) and co-associated protein
identification as complex members. These factors are exempli-
fied by the SH2 and SH3 domain containing protein NCK2.
We identified 46 HCIPs for NCK2 (Table S2), 31 of which are
reported in STRING or GENEMANIA databases as proteins
that interact with NCK2 or NCK2-associated proteins. Of 15
NCK2-associated proteins found in BioPlex, but not in STRING
or GENEMANIA, C3orf10 and SHB are known to interact with
other NCK2-associated proteins, and SEMA6A, KIAA1522,
PEAK1, and SH3PXD2B contain proline-rich sequences of the
type known to associate with SH2 domains or other adaptor el-
ements. Thus, AP-MS provides a complementary approach to
binary interaction measurements for understanding interac-
tome connectivity.
Experimental Challenges of Global Interaction Mapping
via AP-MS
Although AP-MS has proven reliable for interaction mapping,
technical factors have important implications for BioPlex: (1)
some proteins require an intact C terminus for proper complex
assembly and may not provide reliable interacting partners
when C-terminally tagged. Conceivably, some of the 322 baits
that produced no interacting partners are affected by C-termi-
nal tagging. (2) Some baits may be toxic upon expression in
HEK293T cells. Because >93% of bait-expressing cell lines
have survived to harvest, only a small fraction of baits targeted
thus far are toxic. (3) 28% of proteins encoded by ORFEOME
8.1 do not represent the longest ORF in GenBank, which could
affect BioPlex in unpredictable ways. (4) Although bait ex-
pression levels vary, there was no correlation between bait
abundance and HCIP count (Figures S4D and S4E) (Sowa
et al., 2009). In addition, protein associations generally confirm
known bait localizations (Figure S7 and Table S5). Together,
these findings suggest that lentiviral expression has not unduly
biased our network. (5) Up to 1/3 of the genome encodes
membrane proteins. Previous studies have suggested that
extraction conditions can substantially affect membrane pro-
tein complex recovery (Babu et al., 2012). For several well-
studied membrane proteins, our pipeline captured largely
intact membrane protein complexes, including components
of complex I of the electron transport chain (Figure S7C) and
the VAPB complex (Figure 7A). However, for unstudied
trans-membrane proteins, further studies will be requireds was repeated for all domain pairs, and p values were adjusted for multiple
wn function (highlighted in red). Blue boxes label domain pairs that associate at
ices match proteins that contain the indicated domains of unknown function,
es match neither domain. p values were determined by Fisher’s exact test with
entral protein are displayed below each network.
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AB
C
Figure 6. BioPlex Topology Aids Unknown Protein Characterization
(A) Network maps displaying interacting partners (gray) for 271 proteins assigned generic names based on chromosome and ORF position (red). Most are
uncharacterized.
(legend continued on next page)
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to determine whether extraction conditions allow retrieval of
intact complexes.
An additional consideration is that BioPlex incorporates only
one biological replicate for each bait. While technical replicate
LC-MS analyses address some sources of experimental error
and many quality control measures have been implemented,
variability in expression and affinity purification remains. Such ef-
fects would be best addressed with biological replicates, though
our project scope has rendered this impractical. Nevertheless,
as our network has grown to include AP-MS experiments target-
ing much of the human proteome, complexes have been purified
multiple times as each subunit is targeted via AP-MS. These
distinct affinity purifications tend to reinforce each other (e.g.,
Figures 3A, 4C, and 7A). In such cases, the confidence of
our final network is higher than a single IP of an individual bait
would be.
BioPlex Accurately Models the Human Interactome
Notwithstanding challenges, BioPlex appears to accurately
model the human interactome. The accuracy of CompPASS-
Plus is highlighted by its performance on known true and false
positives (Figures S2F and S2G). Furthermore, the reliability of
the resulting interaction network is most apparent from interac-
tions of well-studied baits (Figures 1B and 1C) and from the
extensive overlap observed with CORUM (Figures S2E and
3A). Additionally, subcellular co-localization analysis suggests
that AP-MS interactions achieve accuracies equal or higher
than previous studies and databases (Figure 3E).
Further evidence of BioPlex quality emerges from overall
network architecture. When subdivided into communities (Fig-
ures 4 and S5), 85% reflect functional or structural properties
of their constituent proteins and many correspond to known
complexes, including Mediator and histone acetyltransferase
complexes (Figure S5B), as well as RNA Pol II, the Signalsome,
and CNOT and COMM complexes (Figure 4C), among others
(Table S3). Network structure largely distinguishes proteasome
core and regulatory subunits (Figure 4C). More generally, pat-
terns of domain association (Figures S6 and 5 and Table S4)
and subcellular localization (Figure S7 and Table S5) match ex-
pectations. Many previously unreported interactions involve
understudied proteins whose properties may be revealed by
overlaying GO classification, Pfam domains, and subcellular
localization (Figures 6B and 6C and Tables S5 and S6). By
modeling the interactome in its entirety, BioPlex amounts to
more than the sum of its several thousand constituent AP-MS
experiments.
While BioPlex is drawn from a single cell type, interactionsmay
differ in distinct cell lineages and in response to specific stimuli.
Thus, the network is best viewed as a framework that can be
used for hypothesis generation and for design and interpretation
of targeted studies that address dynamic and genetic underpin-
nings of individual networks, as illustrated through our quantita-
tive analysis of the VAPB complex (Figure 7C).(B) Expected subcellular localizations for 117 of 271 uncharacterized ORFs, ba
neighbors.
(C) Networks surrounding six uncharacterized proteins and listing enriched GO te
Fisher’s exact test with multiple testing correction. Red nodes, ORFs; green nodesConclusions
Utilizing the human ORFEOME, we have assembled the largest
AP-MS network of human interactions. Resulting from AP-MS
analysis of more than 10% of human proteins, BioPlex spans
over 1/3 of the human proteome and includes nearly 24,000
interactions, most of which have not been described. Viewed
individually or in aggregate, these interactions are a valuable
resource for both focused and systems-level biological re-
search. The network will also establish a foundation for future
efforts to expand interactome coverage and to explore network
dynamics and the effect of disease mutations on network
architecture.
EXPERIMENTAL PROCEDURES
An overview of experimental procedures is provided below. See the Supple-
mental Experimental Procedures for details.
Protein Expression and Purification
The sequence-validated Human ORFEOME v. 8.1 (Yang et al., 2011) was used
to construct a lentiviral library containing 13,000 ORFs bearing C-terminal
FLAG-HA epitopes. Following sequence verification and virus production,
HEK293T cells were infected and expanded under puromycin selection.
Upon harvest, cell lysates were clarified and baits captured with anti-HA
agarose prior to washing and elution with HA peptide. Clones will be distrib-
uted through the Dana Farber/Harvard Cancer Center DNA Resource Core
(http://dnaseq.med.harvard.edu/).
Mass Spectrometry
After purification, proteins were precipitated with 10% TCA and digested with
trypsin prior to technical duplicate analyses on ThermoFisher Q-Exactivemass
spectrometers. Using Sequest (Eng et al., 1994), spectra were searched
against human protein sequences from Uniprot (Magrane and Consortium,
2011) and common contaminants. The target-decoy method (Elias and Gygi,
2007) was used to filter each LC-MS dataset to a preliminary 1% protein
FDR. Additional filtering controlled the network FDR (Supplemental Experi-
mental Procedures).
Identification of Interacting Proteins and Network Assembly
An extension of CompPASS (Sowa et al., 2009) called CompPASS-
Plus was developed to distinguish interactors from non-specific back-
ground and false-positive identifications. Interactions were pooled across
AP-MS experiments to assemble BioPlex (Supplemental Experimental
Procedures).
Data Accessibility
BioPlex interactions were deposited into BioGRID in September 2014 and
are available for download and browsing at http://gygi.med.harvard.edu/
projects/bioplex. All 5,200 RAW files are also available. Both BioGRID and
the BioPlex website have been receiving quarterly updates to release addi-
tional AP-MS experiments to the community. At time of publication, data
from a total of 5,884 AP-MS experiments have been released with over
50,000 interactions.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and six tables and can be found online at http://dx.doi.org/10.
1016/j.cell.2015.06.043.sed on localization enrichment among the protein’s primary and secondary
rms, Pfam domains, and subcellular localizations. p values were determined by
, neighboring proteins thatmatch the enriched term highlightedwith green text.
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Figure 7. Quantitative Interaction Proteomics of the VAPB Network Reveals Differential Interactions for VAPB Variants Associated with ALS
(A) BioPlex interaction network for VAPA, VAPB and associated proteins. Dotted red lines: interactions reported by BioGRID; solid black lines: BioPlex
interactions.
(B and C) Overview of our TMT approach for examining how ALS-associated mutations in VAPB affect interaction partners. VAPB and its variants were stably
expressed in SH-SY5Y cells as FLAG-HA-tagged fusion proteins and subjected to AP-MS. Triplicate purifications were digested with trypsin prior to reaction with
(legend continued on next page)
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